Abstract

Myeloid differentiation factor 88 (MyD88) is an adaptor protein that transduces intracellular signaling pathways evoked by the Toll-like receptors (TLRs) and interleukin-1 receptors (IL-1Rs). MyD88 is composed of an N-terminal death domain (DD) and a C-terminal Toll/IL-1 receptor (TIR) domain, separated by a short region. Upon ligand binding, TLR/IL-1Rs hetero- or homodimerize and recruit MyD88 through their respective TIR domains. Then, MyD88 oligomerizes via its DD and TIR domain and interacts with the interleukin-1 receptor-associated kinases (IRAKs) to form the Myddosome complex. We performed site-directed mutagenesis of conserved residues that are located in exposed regions of the MyD88-TIR domain and analyzed the effect of the mutations on MyD88 signaling. Our studies revealed that mutation of Glu(183), Ser(244), and Arg(288) impaired homodimerization of the MyD88-TIR domain, recruitment of IRAKs, and activation of NF-κB. Moreover, overexpression of two green fluorescent protein (GFP)-tagged MyD88 mini-proteins (GFP-MyD88151-189 and GFP-MyD88168-189), comprising the Glu(183) residue, recapitulated these effects. Importantly, expression of these dominant negative MyD88 mini-proteins competed with the function of endogenous MyD88 and interfered with TLR2/4-mediated responses in a human monocytic cell line (THP-1) and in human primary monocyte-derived dendritic cells. Thus, our studies identify novel residues of the TIR domain that are crucially involved in MyD88 homodimerization and TLR signaling in immune cells.

Highlights

  • myeloid differentiation factor 88 (MyD88) is an adaptor protein that plays a crucial role in the immune response

  • We focused on residues present within the flanking regions of three highly conserved motifs denoted box 1, 2, and 3 [17] of the MyD88-Toll/IL-1 receptor (TIR), with specific attention to charged/polar residues that are likely to be involved in protein-protein interactions (Fig. 1A)

  • We selected other residues within the AB and CD loops, as they are located in exposed regions that could play a role in the TIR-TIR interface of the MyD88 dimer

Read more

Summary

Background

MyD88 is an adaptor protein that plays a crucial role in the immune response. Results: We identified residues within the TIR domain of MyD88 required for protein self-association. Our studies identify novel residues of the TIR domain that are crucially involved in MyD88 homodimerization and TLR signaling in immune cells. TLRs are type I transmembrane proteins and comprise an extracellular domain, which mediates the recognition of pathogen-associated molecular patterns, a transmembrane region, and an intracellular Toll-IL-1 receptor (TIR) domain that activates downstream signaling pathways [5]. TIR domains are crucial for TLR/IL-1R signal transduction as they mediate receptor-receptor, receptor-adaptor, and adaptor-adaptor interactions For this reason, they have been the subject of numerous structural and functional studies aimed at identifying the residues participating to homo and hetero interactions [21,22,23,24,25,26]. Our findings identified a novel region of the TIR domain of MyD88 that is crucial for TLR/IL-1R signal transduction

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call